For the DoxyPEP protocol itself — dosing, timing, the dairy rule, the esophagus risk, sun sensitivity, and the decision matrix for when to use it — read Doxycycline After Sex: A Controlled Failsafe first. This guide covers the European-specific picture: why European medicine is cautious, where it's actually available, and how to navigate the gap between the evidence and official guidance.

The Evidence

The US DoxyPEP trial produced numbers that are hard to argue with:

  • 87% reduction in syphilis cases
  • 88% reduction in chlamydia cases
  • 55% reduction in gonorrhea cases

That was enough for the US CDC to formally back DoxyPEP in 2023 — official guidance for gay and bi guys with a recent STI or who are just having a lot of sex.

Current European Status

Unlike the United States, DoxyPEP is not officially recommended by most major European health authorities — not the ECDC, not national health ministries, not most major sexual health organisations. Europe hasn't followed.

Why Europe Is Cautious

The pushback is about antibiotic resistance — and it's not baseless. European healthcare, especially in the Nordic countries, Germany, and the Netherlands, has historically been much stricter about antibiotic prescribing than the US. The worry is that normalising post-exposure antibiotic use, even short-course doxycycline, tips the resistance picture in the wrong direction.

That's a real concern. Europe's tighter antibiotic stewardship has kept a lot of organisms susceptible that have started developing resistance in the US. They're protecting something that matters.

Where It's Actually Available

  • United Kingdom: The most progressive European country on this. Sexual health clinics in London, Manchester, and other major cities have begun offering DoxyPEP, particularly for those with recent STI diagnoses or high-risk exposure.
  • Ireland: Follows the general EU cautious position. Not officially recommended; some sympathetic specialists at the GUIDE Clinic (Dublin) may discuss it. Access requires navigating the same gap between evidence and guidelines as elsewhere in Europe.
  • France: Limited pilot programmes exist in some Paris clinics; remains experimental and not widely available.
  • Germany, Netherlands, Nordic countries: Largely resistant. Most sexual health specialists will not prescribe it routinely, and health insurance typically won't cover it.
  • Southern/Eastern Europe: Minimal access; generally requires private practice doctors.

How to Get It (Practical Reality)

Getting DoxyPEP in most of Europe requires navigating the gap between what the science shows and what official guidelines allow.

  • Contact sexual health/GUM clinics in your area, particularly in major cities. Some sympathetic specialists will prescribe it.
  • Private doctors with sexual health expertise are more likely to prescribe than public healthcare providers.
  • Some people access doxycycline through other prescriptions — for acne or travel malaria prophylaxis. It's the same drug.
  • Cost of doxycycline: roughly €10–20 for a box of tablets. Once you have a prescription, it's very affordable.

The Trade-Off You're Actually Weighing

Here's the tension: syphilis rates are climbing 30–50% year-over-year in major European cities, and 70–90% of gay and bi men don't use condoms consistently. DoxyPEP, targeted at guys with recent STIs or high exposure, could prevent a serious amount of harm — and the resistance risk from targeted use may be much smaller than the resistance risk from undertreated bacterial infections spreading unchecked.

On the other side, Europe's stricter prescribing culture has genuinely kept resistance lower than the US. Normalising post-exposure antibiotics — even selectively — could shift that. More testing and vaccination is a reasonable alternative investment.

This isn't settled. You're not choosing between right and wrong — you're choosing where you sit on that trade-off for yourself.

What DoxyPEP Does NOT Do

  • Does NOT prevent HIV — that's PrEP's function.
  • Does NOT protect against HPV or Hepatitis — vaccines cover those.
  • Does NOT replace regular testing — quarterly three-site testing is still required.
  • Does NOT prevent future infections — it only reduces risk after a specific exposure.

The Bottom Line

The evidence for DoxyPEP is strong. Europe's caution has a real basis. And syphilis and gonorrhea in gay male communities across Europe are genuinely on the rise. If your doctor will prescribe it and you understand it doesn't replace testing or PrEP, it earns its place in your stack.

Related: